Federica Fregonese

Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline

Payam Nahid, Sundari Mase, Giovanni Battista Migliori et al. · American Journal of Respiratory and Critical Care Medicine · 2019 · 453 citations · Full text

Public Health, Pharmacology, Pharmacotherapy +17

Prophylaxis After First Febrile Urinary Tract Infection in Children? A Multicenter, Randomized, Controlled, Noninferiority Trial

Giovanni Montini, Luca Rigon, Pietro Zucchetta et al. · PEDIATRICS · 2008 · 364 citations

Medicine, Child Health, Pediatrics +17

Safety and Side Effects of Rifampin versus Isoniazid in Children

Thierno Diallo, Mênonli Adjobimey, Rovina Ruslami et al. · New England Journal of Medicine · 2018 · 162 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy

Matteo Zignol, Marta Peracchi, Gloria Tridello et al. · Cancer · 2004 · 147 citations

Medicine, Immunology, Pediatrics +13

Adverse events in adults with latent tuberculosis infection receiving daily rifampicin or isoniazid: post-hoc safety analysis of two randomised controlled trials

Jonathon R. Campbell, Anete Trajman, Victoria J. Cook et al. · The Lancet Infectious Diseases · 2019 · 66 citations

Pharmacy, Infectious Diseases, Pharmacology +16